Kura Oncology, Inc.
KURA
$10.86
$0.777.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -296.78M | -294.57M | -278.67M | -216.88M | -197.17M |
| Total Depreciation and Amortization | 1.29M | 1.15M | 1.03M | 833.00K | 877.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.46M | 31.44M | 29.14M | 24.95M | 20.79M |
| Change in Net Operating Assets | 149.27M | 184.00M | 184.44M | 278.90M | 300.50M |
| Cash from Operations | -111.76M | -77.99M | -64.06M | 87.80M | 124.99M |
| Capital Expenditure | -5.67M | -6.47M | -6.64M | -4.69M | -2.12M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 103.02M | 70.55M | -6.46M | -38.77M | -89.77M |
| Cash from Investing | 97.35M | 64.08M | -13.10M | -43.46M | -91.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.70M | 1.72M | 1.79M | 1.46M | 3.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.70M | 1.72M | 1.79M | 1.46M | 3.67M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.71M | -12.19M | -75.36M | 45.81M | 36.77M |